1Devesa SS, Blot WJ, Stone BJ, Miller BA, Tarone RE, Fraumeni JF Jr. Recent cancer trends in the united states. J Natl Cancer Inst 1995; 87:175-182.
2Bundesamt S. Statistical year book for the Federal Republic of Germany. Metzler Poeschel Stuttgart 1996:430-433.
3Yeo TP, Hruban RH, Leach SD, Wilentz RE, Sohn TA, Kern SE,Iacobuzio-Donahue CA, Maitra A, Goggins M, Canto MI, Abrams RA, Laheru D, Jaffee EM, Hidalgo M, Yeo CJ. Pancreatic cancer Curr Probl Cancer 2002; 26:176-275.
4Yeo CJ, Abrams RA, Grochow LB, Sohn TA, Ord SE, Hruban RH, Zahurak ML, Dooley WC, Coleman J, Sauter PK, Pitt HA,Lillemoe KD, Cameron JL. Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoraciiation improves survival. A prospective, single-institution experience.Ann Surg 1997; 225:621-633.
5Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics.Nat Rev Cancer 2002; 2:897-909.
6Sohn TA. The molecular genetics of pancreatic ductal carcinoma.Minerva Chir 2002; 57:561-574.
7Farrow B, Evers BM. Inflammation and the development of pancreatic cancer. Surg Oncol 2002; 10:153-169.
8Hall Pde L, Wilentz RE, de Klerk W, Bomman PP. Premalignant conditions of the pancreas. Pathology 2002; 34:504-517.
9Knowles RG, Moncada S. Nitric oxide synthases in mammals.Biochem J 1994; 298(Pt2): 249-258.
10Moncada S, Higgs A. The 1-arginine-nitric oxide pathway. N Engl J Med 1993; 329:2002-2012.
4Kaku Toyoma,Ono Takamasa,Kawabe Ken,et al.Advanced pancreatic cancer with metastasis to the spermatic cord.Journal of the Japan Pancreas Society 2005;20(4):400-406.
